Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
|
Adenosine- Action
|
Decreases conduction throught the AV Node
|
|
|
Adenosine- Indication
|
Symptomatic Supraventricular Tachycardia, Effective in terminating re-entyr arrhythmias due to AV or Sinus node
|
|
|
Adenosine- Contraindications
|
2nd or 3rd degree heart block, Sick Sinus Syndrome, Drug/Poison Tachycardia
|
|
|
Adenosine- Side Effects
|
Paroxysmal dysrhythmias, Facial Flushing, SOB, Dizziness, Syncope. frequently cause brief periods of asystole.
|
|
|
Adenosine- Precautions
|
Does not convert A-fib/Flutter or V-Tach
|
|
|
Adenosine- Supplied
|
6mg/2ml flip-top Vial (typical), 6mg and 12mg prefilled syringe
|
|
|
Adenosine- Drug Route
|
Adult: 6mg RIVP, maybe repeated (X2) in 1-2min by 12mg RIVP if needed.
Pedi: 0.1mg/kg IV/IO, followed in 1-2min with 0.2mg/kg IV/IO; Max 6mg then 12mg |
|
|
Atropine Sulfate- Action
|
Bloack acetylcholine at muscarinic site blocking the parasympathetic nervous system, allowing the sympathetic nervous system to temporarily take over
|
|
|
Atropine Sulfate- Indications
|
Symptomatic bradycardia, Asystole, Pulseless Electrical Activity (PEA), Cholinergic (organophosphates) Poisoning, Nerve agents
|
|
|
Atropine Sulfate- Contraindications
|
Tachycardias, Glaucoma
|
|
|
Atropine Sulfate- Side Effects
|
Tachycardia, Dysrhythmias, exacerbation of glaucoma, pupil dilation, dry mouth, urine retention. Atropine can cause tachycardia, thus increasing myocardial oxygen demand which exacerbates myocardial infarction.
|
|
|
Atropine Sulfate- Supplied
|
Prefilled Syringe 1mg/10ml (typical); Vial 1mg/ml
|
|
|
Atropine Sulfate- Drug Route
|
Symptomatic Bradycardia, or vagally mediated bradycardia: Adult: 0.5mg IV may be repeated q 3min, max dose is 3 mg
Pedi: 0.02mg/kg IV/IO (Minimum single dose 0.1mg Maximum single dose 0.5mg) Asystole or PEA: Adult: 1mg every 3 to 5 min, maximum dose is 3mg Oroganophosphate Poising: Adult: 2mg to 5mg q 15 min until cessation of secreations. Pedi: 0.05mg/kg q 5 to 15 min until cessation of secretions. |
|
|
Amiodrone- Action
|
Prolongs the refactory period and action potential duration, decreases ventricular conduction, automaticity, and excitability. Class III antidysrythmic
|
|
|
Amiodrone- Indication
|
V-Fib, V-Tach, Wide complex Tach of unknown origin, Atrial Dyshrythmias.
|
|
|
Amiodrone- Contraindications
|
2nd or 3rd degree heartblock, Ventricular escape rhythms.
|
|
|
Amiodrone- Side effects
|
Cause profound hypotension, decreases myocardial contractility, prolong the QT interval
|
|
|
Amiodrone-Supplied
|
150mg in 3ml ampule or vial
|
|
|
Amiodrone- Precautions
|
Terminal elimination is extremely long (half life of 40 days), has negative intropic and chronotropic effects, will foam up if shaken, be cautious with other drugs the prolong the QT interval (ie Procainamide)
|
|
|
Amiodrone-Drug Route
|
Adult: 300mg IV bolus in cardiac arrest, may repeat once at 150mg (VF/VT)
150mg IV Drip over 10 min in VT with pulses or Atrial Dysrhythmias Pedi: 5mg/kg IV/IO bolusin cardiac arrest 5mg/kg IV/IO drip over 20-60 minutes in rhythms with pulses not recomended for neonates |
